Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2024-04-25 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
董事会战略委员会工作细则
Governance Information Classification · 100% confidence The document is titled '董事会战略委员会工作细则' which translates to 'Board Strategic Committee Working Rules'. It details the structure, responsibilities, membership, meeting procedures, and governance of the Board's Strategic Committee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no announcements of reports, or any other typical financial or regulatory content. The document is a governance-related internal rules document about the board committee's operation and responsibilities. Therefore, it fits best under Governance Information (CGR). The document length is 2494 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2024-04-25 Chinese
融资与对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '融资与对外担保管理制度' which translates to 'Financing and External Guarantee Management System'. It is a detailed internal policy document outlining the company's procedures, approval processes, risk management, and disclosure obligations related to financing and external guarantees. It references relevant laws and regulations, describes internal controls, approval authorities, and responsibilities of company personnel. There is no indication that this is a financial report, audit report, earnings release, or any form of regulatory filing or announcement. Instead, it is a governance-related document detailing internal rules and management practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5208 characters) and content support this classification with high confidence.
2024-04-25 Chinese
监事会议事规则
Governance Information Classification · 100% confidence The document is titled '监事会议事规则' which translates to 'Supervisory Board Meeting Rules' and is issued by 西藏易明西雅医药科技股份有限公司. The content details the rules, procedures, powers, composition, meeting protocols, and responsibilities of the Supervisory Board (监事会) of the company. It includes references to legal compliance, meeting convocations, voting procedures, and supervisory duties over the board and management. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related internal rules document outlining the structure and operation of the Supervisory Board. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-04-25 Chinese
关于设立分公司的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the establishment of a branch office (成都分公司) by the company 西藏易明西雅医药科技股份有限公司. It includes details about the board meeting resolution approving this action and states that it does not require shareholder approval. The document is short (850 characters) and focuses on corporate structural changes rather than financial results, governance rules, or regulatory filings. It is not a full report, financial statement, or earnings release. It is also not a notice of voting results or a proxy solicitation. The content fits best under Board/Management Information (MANG) as it relates to a board decision about company structure and management organization.
2024-04-25 Chinese
关于2023年计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the asset impairment provisions for the year 2023. It details the reasons, amounts, accounting standards applied, and the impact on financial statements. The document is relatively short (3698 characters) and is structured as a formal announcement rather than a full financial report. It does not contain full financial statements or comprehensive financial analysis but rather a specific disclosure about impairment provisions approved by the board. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about accounting estimates and provisions, not a full Annual Report (10-K) or Interim Report (IR).
2024-04-25 Chinese
重大信息内部保密制度
Governance Information Classification · 95% confidence The document is titled '重大信息内部保密制度' which translates to 'Material Information Internal Confidentiality System' and is issued by 西藏易明西雅医药科技股份有限公司. The content details the company's internal policies and procedures for handling material non-public information, insider information, confidentiality obligations, and penalties for violations. It references relevant laws and regulations governing insider trading and confidentiality. There is no indication that this is a financial report, earnings release, or any form of regulatory filing announcing financial results or corporate actions. Instead, it is a governance-related document outlining internal rules and compliance measures related to information disclosure and insider information management. Therefore, the document fits best under Governance Information (CGR). The document length (5614 characters) and detailed procedural content support this classification rather than a brief announcement or regulatory filing.
2024-04-25 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.